Company intelligence / Profile preview

Bioter

Ranelagh, Buenos Aires, Argentina

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Bioter is an Argentine biotechnology company specializing in animal nutrition and health solutions. The company develops and manufactures high-tech nutritional products, including additives, premixes, and specialized diets for livestock, particularly in the swine and poultry sectors. Bioter leverages biotechnological research to optimize animal performance, improve feed efficiency, and promote sustainable production practices. Their portfolio includes a range of biological solutions designed to enhance gut health and overall immunity in production animals.

Modalities: BiologicMicrobial therapyPeptides
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Bioter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioter.

Explore the full profile